Clinical Trials in Houston

Showing 10421-10440 of 15,366 trials

Letrozole Versus Observation in Patients With Newly Diagnosed Uterine Leiomyosarcoma

NCT00414076

The goal of this clinical research study is learn if taking Femara (letrozole) after a hysterectomy (surgical removal of the uterus) for uterine leiomyosarcoma will delay or prevent the cancer from coming back.

LeiomyosarcomaUterine Neoplasm

M.D. Anderson Cancer Center9 participantsStarted Dec 2006

Houston, Texas, United States

COMPLETEDNA< 1 mile

R-21 Colorectal Cancer Screening (CRCS) Pilot Trial

NCT01492049

The goal of this study is to test patient education program for decision making about colorectal cancer (CRC) screening in community health centers.

Colorectal Neoplasms

M.D. Anderson Cancer Center107 participantsStarted Aug 2012

Houston, Texas, United States

COMPLETEDPhase 2< 1 mile

Safety and Efficacy of Idelalisib in Relapsed or Refractory Hodgkin Lymphoma

NCT01393106

This study will evaluate the efficacy and safety of idelalisib in participants with relapsed of refractory Hodgkin Lymphoma (HL). The primary objective will be to assess the overall response rate. Eligible participants will initiate oral therapy with idelalisib at a starting dose of 150 mg twice daily. Treatment with idelalisib will continue until tumor progression or unacceptable toxicity.

Hodgkin Lymphoma

Gilead Sciences25 participantsStarted Sep 2011

New York, New York, United States • Houston, Texas, United States • Seattle, Washington, United States

Letrozole Versus Observation in Patients With Newly Diagnosed Uterine Leiomyosarcoma

R-21 Colorectal Cancer Screening (CRCS) Pilot Trial

Safety and Efficacy of Idelalisib in Relapsed or Refractory Hodgkin Lymphoma

Find Trials by Condition in Houston

Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination for 12 Weeks in Subjects With Chronic Genotype 1 or 4 HCV and HIV-1 Co-infection

A Study Of Deoxycoformycin(DCF)/Pentostatin In Lymphoid Malignancies

A Study of Idelalisib and Rituximab in Elderly Patients With Untreated CLL or SLL

Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination ± Ribavirin for the Treatment of HCV (ION-3)

Pharmacotherapy Dosing Regimen in Cocaine and Opiate Dependent Individuals - 8

Decitabine and Clofarabine in Higher Risk Myelodysplastic Syndromes (MDS)

Sodium Stibogluconate With Interferon Alpha-2b for Patients With Advanced Malignancies

Series of N-of-1 Crossover Trials of Antihypertensive Therapy in Adolescents With Essential Hypertension

Efficacy and Safety of Idelalisib (GS-1101) in Combination With Bendamustine and Rituximab for Previously Treated Indolent Non-Hodgkin Lymphomas

Comparison of Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks With Sofosbuvir and Ribavirin for 24 Weeks in Adults With Chronic Genotype 3 HCV Infection

Efficacy And Safety Of Sofosbuvir/Velpatasvir Fixed Dose Combination With Ribavirin in Chronic HCV Infected Adults Who Participated in a Prior Gilead Sponsored HCV Treatment Study

Safety and Efficacy of Sofosbuvir Plus Velpatasvir With or Without Ribavirin in Treatment-experienced Subjects With Chronic HCV Infection

ALK21-025: Vivitrol's Cost and Treatment Outcomes Registry

Safety Study of HemaMax™ (rHuIL-12) to Treat Acute Radiation Syndrome

Best African American Response to Asthma Drugs

Efficacy and Safety of Idelalisib in Combination With Obinutuzumab Compared to Chlorambucil in Combination With Obinutuzumab for Previously Untreated Chronic Lymphocytic Leukemia

Ledipasvir/Sofosbuvir Fixed-Dose Combination Plus Ribavirin in Participants With Chronic HCV With Advanced Liver Disease or Post-Liver Transplant